Extend Biosciences Inc is a biotechnology company based in Newton, MA that specializes in the development of innovative therapies for various medical conditions. Their cutting-edge D-VITylation technology has shown promising results in the treatment of hypoparathyroidism and cancer cachexia, as evidenced by positive data from phase 1 trials and published manuscripts. With a START II grant from MassVentures, Extend Biosciences is actively advancing their pipeline and has recently commenced human testing of their lead candidate, EXT608.
Generated from the website